Arcus Biosciences, Inc. (RCUS) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -138M | -120M | -97M | -133M | -132M | -100M | 26M | -94M | -2M | -88M | -63M | -57M | -98M | -69.74M | -80.96M | -65M | 654M | -62.1M | -53.76M | -74M |
| Operating CF Margin % | -811.76% | -363.64% | -373.08% | -83.13% | -471.43% | -384.62% | 54.17% | -241.03% | -1.38% | -283.87% | -196.88% | -196.55% | -392% | -207.22% | -245.33% | -240.74% | 3633.34% | -17.52% | -568.2% | -782.11% |
| Operating CF Growth % | -4.55% | -20% | -473.08% | -41.49% | -6500% | -13.64% | 141.27% | -64.91% | 97.96% | -26.18% | 22.18% | 12.31% | -114.98% | -12.3% | -50.6% | 12.16% | 1086.19% | -24.5% | -124.86% | -209.11% |
| Net Income | -128M | -106M | -135M | 0 | -112M | -94M | -92M | -93M | -4M | -81M | -71M | -75M | -80M | -67.46M | -64.92M | -67M | -67.99M | 279.37M | -77.97M | -75.97M |
| Depreciation & Amortization | 2M | 3M | 2M | 2M | 3M | 3M | 2M | 2M | 3M | 5M | 1M | 2M | 4M | 3.43M | 3.61M | 2M | 3.43M | 2.47M | 1.65M | 820K |
| Stock-Based Compensation | 19M | 15M | 14M | 15M | 16M | 17M | 19M | 20M | 20M | 0 | 18M | 18M | 0 | 0 | 0 | 15M | 0 | 0 | 0 | 13.37M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -29M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -31M | -2M | 1M | -2M | -2M | -3M | -4M | -4M | 16M | 12M | 27M | -2M | 16M | 14.82M | 15.18M | 3M | 21.1M | 16.34M | 15.88M | 1.49M |
| Working Capital Changes | 0 | -30M | 21M | -148M | -37M | -23M | 101M | -19M | -37M | -24M | -9M | 0 | -38M | -20.54M | -34.83M | -18M | 697.46M | -360.29M | 6.69M | -13.7M |
| Change in Receivables | 0 | 0 | 4M | 0 | 5M | -4M | 12M | 7M | 13M | 0 | 11M | -2M | 6M | -8.9M | 5.32M | -6M | 715.27M | -15.82M | 302K | 3.66M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -3M | 0 | 13M | 8M | 3M | 5M | -1M | 0 | -1M | 2M | 6M | -19M | 10M | 8.05M | -12.16M | 4M | 8.14M | 651K | -1.85M | -11.29M |
| Cash from Investing | 114M | -182M | 79M | 137M | 32M | 51M | -29M | 63M | -169M | 28M | 11M | 26M | 129M | 46.81M | 23.45M | -215M | -268.06M | 18.91M | -88.61M | 3M |
| Capital Expenditures | 0 | -1M | 0 | 0 | -1M | -1M | -1M | 0 | -4M | -6M | -10M | -5M | -3M | -380K | -1.32M | -1M | -2.79M | -8.51M | -7.86M | -6.07M |
| CapEx % of Revenue | - | 3.03% | - | - | 3.57% | 3.85% | 2.08% | - | 2.76% | 19.35% | 31.25% | 17.24% | 12% | 1.13% | 3.99% | 3.7% | 15.49% | 2.4% | 83.06% | 64.19% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -21M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21M | 0 | 0 | -250K | 2.75M | -6M | 0 | 0 | 0 | 0 |
| Cash from Financing | 3M | 286M | 8M | 52M | 142M | -2M | 48M | 2M | 229M | 3M | 6M | 23M | 1M | 11.2M | 2.53M | 4M | 14.93M | 11.67M | 1.32M | 2.23M |
| Debt Issued (Net) | 0 | 0 | 0 | 49M | 0 | 0 | 47M | 0 | 0 | 0 | 0 | 0 | 0 | 5M | 0 | 0 | 5M | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 286M | 8M | 3M | 142M | 0 | 0 | 3M | 228M | 3M | 5M | 20M | 1M | 6.2M | 2.53M | -10M | 9.93M | 6.67M | 1.32M | -6K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6K |
| Other Financing | 3M | 0 | 0 | 0 | 0 | -2M | 1M | -1M | 1M | 0 | 1M | 3M | 0 | 0 | 0 | 14M | 0 | 5M | 0 | 2.24M |
| Net Change in Cash | -21M | -16M | -10M | 56M | 42M | -51M | 45M | -29M | 58M | -57M | -46M | -8M | 32M | -11.65M | -54.98M | -276M | 400.87M | -31.52M | -141.05M | -68.76M |
| Free Cash Flow | -138M | -121M | -97M | -133M | -133M | -101M | 25M | -94M | -6M | -94M | -73M | -62M | -101M | -70.12M | -82.28M | -72M | 651.21M | -70.61M | -61.62M | -80.07M |
| FCF Margin % | -811.76% | -366.67% | -373.08% | -83.13% | -475% | -388.46% | 52.08% | -241.03% | -4.14% | -303.23% | -228.13% | -213.79% | -404% | -208.35% | -249.32% | -266.67% | 3617.85% | -19.92% | -651.25% | -846.3% |
| FCF Growth % | -3.76% | -19.8% | -488% | -41.49% | -2116.67% | -7.45% | 134.25% | -51.61% | 94.06% | -34.06% | 11.28% | 13.89% | -115.51% | 0.69% | -33.53% | 10.08% | 1030.88% | -37.37% | -128.63% | -230.94% |
| FCF per Share | -1.10 | -1.13 | -0.91 | -1.25 | -1.35 | -1.10 | 0.27 | -1.03 | -0.07 | -1.25 | -0.98 | -0.85 | -1.38 | -0.97 | -1.14 | -1.00 | 9.15 | -0.94 | -0.88 | -1.15 |
| FCF Conversion (FCF/Net Income) | 1.08x | 1.22x | 0.72x | 16.63x | 1.18x | 1.06x | -0.28x | 1.01x | 0.50x | 1.09x | 0.89x | 0.76x | 1.23x | 1.03x | 1.25x | 0.97x | -9.62x | -0.22x | 0.69x | 0.97x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |